178 related articles for article (PubMed ID: 33058005)
1. TSH lowering effects of metformin: a possible mechanism of action.
Cannarella R; Condorelli RA; Barbagallo F; Aversa A; Calogero AE; La Vignera S
J Endocrinol Invest; 2021 Jul; 44(7):1547-1550. PubMed ID: 33058005
[TBL] [Abstract][Full Text] [Related]
2. Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes.
Díez JJ; Iglesias P
Clin Endocrinol (Oxf); 2013 Apr; 78(4):505-11. PubMed ID: 22686474
[TBL] [Abstract][Full Text] [Related]
3. Role of Metformin in the Treatment of Patients with Thyroid Nodules and Insulin Resistance: A Systematic Review and Meta-Analysis.
He X; Wu D; Hu C; Xu T; Liu Y; Liu C; Xu B; Tang W
Thyroid; 2019 Mar; 29(3):359-367. PubMed ID: 30595105
[TBL] [Abstract][Full Text] [Related]
4. Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus.
Fournier JP; Yin H; Yu OH; Azoulay L
CMAJ; 2014 Oct; 186(15):1138-45. PubMed ID: 25246411
[TBL] [Abstract][Full Text] [Related]
5. The effect of metformin on TSH levels in euthyroid and hypothyroid newly diagnosed diabetes mellitus type 2 patients.
Dimic D; Golubovic MV; Radenkovic S; Radojkovic D; Pesic M
Bratisl Lek Listy; 2016; 117(8):433-5. PubMed ID: 27546693
[TBL] [Abstract][Full Text] [Related]
6. TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients.
Cappelli C; Rotondi M; Pirola I; Agosti B; Gandossi E; Valentini U; De Martino E; Cimino A; Chiovato L; Agabiti-Rosei E; Castellano M
Diabetes Care; 2009 Sep; 32(9):1589-90. PubMed ID: 19502536
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin suppression by metformin.
Vigersky RA; Filmore-Nassar A; Glass AR
J Clin Endocrinol Metab; 2006 Jan; 91(1):225-7. PubMed ID: 16219720
[TBL] [Abstract][Full Text] [Related]
8. Does metformin have a "buffer effect" on serum TSH levels in euthyroid diabetic patients?
Santos-Palacios S; Brugos-Larumbe A; Guillén-Grima F; Garmendia-Madariaga A; Galofré JC
Hormones (Athens); 2015; 14(2):280-5. PubMed ID: 25553761
[TBL] [Abstract][Full Text] [Related]
9. [During therapy with metformin pay attention to TSH!].
Füessl HS
MMW Fortschr Med; 2014 Nov; 156(20):38. PubMed ID: 25543363
[No Abstract] [Full Text] [Related]
10. Metformin-induced thyrotropin suppression is not associated with cardiac effects.
Cappelli C; Rotondi M; Pirola I; Agosti B; Formenti AM; De Cata P; Salvetti M; Chiovato L; Castellano M
Hormones (Athens); 2014; 13(2):252-8. PubMed ID: 24776625
[TBL] [Abstract][Full Text] [Related]
11. The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism.
Krysiak R; Gilowska M; Szkróbka W; Okopień B
Pharmacol Rep; 2016 Apr; 68(2):490-4. PubMed ID: 26922558
[TBL] [Abstract][Full Text] [Related]
12. Genetics and phenomics of hypothyroidism due to TSH resistance.
Persani L; Calebiro D; Cordella D; Weber G; Gelmini G; Libri D; de Filippis T; Bonomi M
Mol Cell Endocrinol; 2010 Jun; 322(1-2):72-82. PubMed ID: 20083154
[TBL] [Abstract][Full Text] [Related]
13. The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and subclinical hyperthyroidism.
Krysiak R; Szkrobka W; Okopien B
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):205-8. PubMed ID: 25658660
[TBL] [Abstract][Full Text] [Related]
14. No detection of TSH or TSHR in oral lichen planus lesions in patients with or without hypothyroidism.
Vehviläinen M; Salem A; Asghar MY; Salo T; Siponen M
Acta Odontol Scand; 2020 Jul; 78(5):337-344. PubMed ID: 32031461
[No Abstract] [Full Text] [Related]
15. Deletion of thyrotropin receptor residue Asp403 in a hyperfunctioning thyroid nodule provides insight into the role of the ectodomain in ligand-induced receptor activation.
Nishihara E; Chen CR; Mizutori-Sasai Y; Ito M; Kubota S; Amino N; Miyauchi A; Rapoport B
J Endocrinol Invest; 2012 Jan; 35(1):49-53. PubMed ID: 21597314
[TBL] [Abstract][Full Text] [Related]
16. Metformin and thyroid disease.
Meng X; Xu S; Chen G; Derwahl M; Liu C
J Endocrinol; 2017 Apr; 233(1):R43-R51. PubMed ID: 28196954
[TBL] [Abstract][Full Text] [Related]
17. Thyreotropin levels in diabetic patients on metformin treatment.
Cappelli C; Rotondi M; Pirola I; Agosti B; Formenti A; Zarra E; Valentini U; Leporati P; Chiovato L; Castellano M
Eur J Endocrinol; 2012 Aug; 167(2):261-5. PubMed ID: 22645202
[TBL] [Abstract][Full Text] [Related]
18. Association between worse metabolic control and increased thyroid volume and nodular disease in elderly adults with metabolic syndrome.
Blanc E; Ponce C; Brodschi D; Nepote A; Barreto A; Schnitman M; Fossati P; Salgado P; Cejas C; Faingold C; Musso C; Brenta G
Metab Syndr Relat Disord; 2015 Jun; 13(5):221-6. PubMed ID: 25789844
[TBL] [Abstract][Full Text] [Related]
19. TSH/IGF1 receptor crosstalk: Mechanism and clinical implications.
Krieger CC; Neumann S; Gershengorn MC
Pharmacol Ther; 2020 May; 209():107502. PubMed ID: 32061922
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-1 enhances the expression of functional TSH receptor in orbital fibroblasts from thyroid-associated ophthalmopathy.
Paik JS; Kim SE; Kim JH; Lee JY; Yang SW; Lee SB
Immunobiology; 2020 Mar; 225(2):151902. PubMed ID: 31899052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
